Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identification of Tricyclic Agonists of Sphingosine-1-Phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.
Gait Profile Score in multiple sclerosis patients with low disability.
Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy, a time to start and a time to stop.
The N-MOmentum trial: Building momentum to advance trial methodology in a rare disease.
In vitro and ex vivo models of multiple sclerosis.
When Evaluating a New Thyroid Mass and a Ring-Enhancing Brain Lesion (When Two Presentations Collide).
Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.
Effect of dual-task-induced uncertainty on gait biomechanics in patients with multiple sclerosis with 2-6.5 EDSS grade.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).
Pathologic and Protective Roles for Microglial Subsets and Bone Marrow- and Blood-Derived Myeloid Cells in Central Nervous System Inflammation.
Brain structural connectivity in late-life major depressive disorder.
Variations in multiple sclerosis practice within Europe - Is it time for a new treatment guideline?
Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.
A case of a 17-year-old male with neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy presenting with tremor and ataxia.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Patient fibroblasts-derived induced neurons demonstrate autonomous neuronal defects in adult-onset Krabbe disease.
Moringin activates Wnt canonical pathway by inhibiting GSK3β in a mouse model of experimental autoimmune encephalomyelitis.
Short-Lived Human Umbilical Cord-Blood-Derived Neural Stem Cells Influence the Endogenous Secretome and Increase the Number of Endogenous Neural Progenitors in a Rat Model of Lacunar Stroke.
Pathological mechanism of secondary-progressive multiples sclerosis and its animal model.
Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
Effect of oscillating electrical field stimulation on motor function recovery and myelin regeneration after spinal cord injury in rats.
Evidence of Hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system.
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis.
Urbanization Theory for Growing Trend of Multiple Sclerosis Prevalence among Iranian Population.
Pages
« first
‹ previous
…
768
769
770
771
772
773
774
775
776
…
next ›
last »